SCHEMBL271545

SCHEMBL271545

CC(C)C(C)(O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10297565 1.00
SCHEMBL10297566 1.00
SCHEMBL8624733 0.81 TSHR (0.36)
SCHEMBL703096 0.78
SCHEMBL5872623 0.76 ALDH1A1 (0.41)
SCHEMBL16885352 0.75 TSHR (0.30)
SCHEMBL8516870 0.75
SCHEMBL16330822 0.75
SCHEMBL268885 0.75
SCHEMBL8368057 0.75 TSHR (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 134 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250369024-A1 Acyloin Condensation Reactions, Enzymes, and Products Thereof MOJIA BIOTECH PTE LTD (SG) 2025-12-04 US claimed
EP-4649157-A2 ACYLOIN CONDENSATION REACTIONS, ENZYMES, AND PRODUCTS THEREOF Mojia Biotech Pte. Ltd. (SG) 2025-11-19 EP claimed
WO-2024150067-A2 ACYLOIN CONDENSATION REACTIONS, ENZYMES, AND PRODUCTS THEREOF MOJIA BIOTECH PTE. LTD. (SG) 2024-07-18 WO claimed
US-20110046059-A1 PHARMACEUTICALLY ACCEPTABLE FORMULATIONS/COMPOSITIONS FOR PEPTIDYL DRUGS ZELOS THERAPEUTICS, INC. (US) 2011-02-24 US claimed
WO-2011011675-A1 PHARMACEUTICALLY ACCEPTABLE FORMULATIONS/COMPOSITIONS FOR PEPTIDYL DRUGS ZELOS THERAPEUTICS, INC. (US) 2011-01-27 WO claimed
EP-1692123-B1 PHENYL-FURAN COMPOUNDS AS VITAMIN D RECEPTOR MODULATORS LILLY CO ELI (US) 2008-05-28 EP claimed
US-20070105951-A1 Phenyl-furan compounds as vitamin d receptor modulators ELI LILLY AND COMPANY 2007-05-10 US claimed
CN-1110541-C Concentrated water-dispersible stable fiber softener compositions PROCTER & GAMBLE (US) 2003-06-04 CN claimed
CN-1098350-C Fabric softening compound/composition PROCTER & GAMBLE (US) 2003-01-08 CN claimed
EP-0957903-A4 PHARMACEUTICAL COMPOSITIONS AND METHODS CODON PHARMACEUTICALS INC (US) 2002-10-09 EP claimed
US-20020141952-A1 Regulating the melanin content of mammalian melanocytes by administering alcohols, diols, triols and their analogues APPLIED GENETICS INCORPORATED DERMATICS 2002-10-03 US claimed
CN-1244212-A Improved expression vectors PROCTER & GAMBLE (US) 2000-02-09 CN claimed
EP-0957903-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS Codon Pharmaceuticals, Inc. (US) 1999-11-24 EP claimed
US-5990177-A CYCLIC AND ACYCLIC MONO-, DI- AND TRIALCOHOLS AS STIMULANTS TO TREAT DISEASES MEDIATED BY DEFICIENCIES IN THE NITRIC OXIDE/CYCLIC GUANOSINE MONOPHOSPHATE/PROTEIN KINASE G SIGNAL TRANSDUCTION PATHWAY; CARDIOVASCULAR; SKIN; NERVOUS SYSTEM CODON PHARMACEUTICALS, INC. (US) 1999-11-23 US claimed
CN-1219953-A Fabric softening compound/composition PROCTER & GAMBLE (US) 1999-06-16 CN claimed
WO-1998055085-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS CODON PHARMACEUTICALS, INC. (US) 1998-12-10 WO claimed
CN-1196081-A Concentrated, water dispersible, stable, fabric softening compositions PROCTER & GAMBLE (US) 1998-10-14 CN claimed
CN-1195369-A Concentrated and stable fabric softening compositions PROCTER & GAMBLE (US) 1998-10-07 CN claimed
WO-1998011882-A1 PHARMACEUTICAL COMPOSITIONS AND METHODS CODON PHARMACEUTICALS, INC. (US) 1998-03-26 WO claimed
US-12600853-B2 Epoxy resin composition, prepreg, and fiber reinforced composite material TORAY INDUSTRIES, INC. (JP) 2026-04-14 US disclosed
US-20260078416-A1 ORTHOGONAL METABOLIC FRAMEWORK FOR ONE-CARBON UTILIZATION MOJIA BIOTECH PTE LTD (SG) 2026-03-19 US disclosed
US-20250369024-A1 Acyloin Condensation Reactions, Enzymes, and Products Thereof MOJIA BIOTECH PTE LTD (SG) 2025-12-04 US disclosed
EP-4649157-A2 ACYLOIN CONDENSATION REACTIONS, ENZYMES, AND PRODUCTS THEREOF Mojia Biotech Pte. Ltd. (SG) 2025-11-19 EP disclosed
WO-2025022124-A2 METHODS FOR DEPOLYMERISING AND REPOLYMERISING Epoch Biodesign Ltd (GB) 2025-01-30 WO disclosed
US-20240410055-A1 METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS MERCK PATENT GMBH (DE) 2024-12-12 US disclosed
CN-114729107-B Epoxy resin composition, prepreg and fiber-reinforced composite material 东丽株式会社 2024-08-02 CN disclosed
WO-2024150067-A2 ACYLOIN CONDENSATION REACTIONS, ENZYMES, AND PRODUCTS THEREOF MOJIA BIOTECH PTE. LTD. (SG) 2024-07-18 WO disclosed
US-20240229047-A1 CARBOXYLIC ACID PLATFORM FOR FUEL AND CHEMICAL PRODUCTION AT HIGH CARBON AND ENERGY EFFICIENCY MOJIA BIOTECH PTE LTD (SG) 2024-07-11 US disclosed
EP-4388104-A2 ORTHOGONAL METABOLIC FRAMEWORK FOR ONE-CARBON UTILIZATION Mojia Biotech Pte. Ltd. (SG) 2024-06-26 EP disclosed
CN-118251496-A Carboxylic acid platforms for high carbon and energy efficient fuel and chemical production 摩珈生物科技有限公司 2024-06-25 CN disclosed
CN-118076767-A Method and formulation for producing an optical metal oxide layer 默克专利有限公司 2024-05-24 CN disclosed
WO-2023057401-A1 METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS MERCK PATENT GMBH (DE) 2023-04-13 WO disclosed
WO-2023023097-A2 ORTHOGONAL METABOLIC FRAMEWORK FOR ONE-CARBON UTILIZATION UNIVERSITY OF SOUTH FLORIDA (US) 2023-02-23 WO disclosed
WO-2023287814-A2 CARBOXYLIC ACID PLATFORM FOR FUEL AND CHEMICAL PRODUCTION AT HIGH CARBON AND ENERGY EFFICIENCY UNIVERSITY OF SOUTH FLORIDA (US) 2023-01-19 WO disclosed
US-20220411626-A1 EPOXY RESIN COMPOSITION, PREPREG, AND FIBER REINFORCED COMPOSITE MATERIAL TORAY INDUSTRIES, INC. (JP) 2022-12-29 US disclosed
EP-4059977-A1 EPOXY RESIN COMPOSITION, PREPREG, AND FIBER-REINFORCED COMPOSITE MATERIAL Toray Industries, Inc. (JP) 2022-09-21 EP disclosed
CN-114729107-A Epoxy resin composition, prepreg, and fiber-reinforced composite material 东丽株式会社 2022-07-08 CN disclosed
WO-2019142760-A1 HYALURONIDASE ACTIVITY INHIBITOR 株式会社ADEKA 2019-07-25 WO disclosed
US-10011729-B2 Ink, method for producing ink, ink storage container, recording device, and recording method RICOH COMPANY, LTD. (JP) 2018-07-03 US disclosed
US-20170342286-A1 INK, METHOD FOR PRODUCING INK, INK STORAGE CONTAINER, RECORDING DEVICE, AND RECORDING METHOD RICOH COMPANY, LTD. (JP) 2017-11-30 US disclosed
US-9376418-B2 Substituted pyridine spleen tyrosine kinase (SYK) inhibitors MERCK SHARP & DOHME CORP. (US) 2016-06-28 US disclosed
US-9188866-B2 Composition for forming titanium-containing resist underlayer film and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-11-17 US disclosed
US-9176382-B2 Composition for forming titanium-containing resist underlayer film and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-11-03 US disclosed
US-9176382-B2 Composition for forming titanium-containing resist underlayer film and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-11-03 US disclosed
US-9079890-B2 Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivatives ARRAY BIOPHARMA INC. (US) 2015-07-14 US disclosed
US-9079890-B2 Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivatives ARRAY BIOPHARMA INC. (US) 2015-07-14 US disclosed
US-20150148327-A1 SUBSTITUTED PYRIDINE SPLEEN TYROSINE KINASE (SYK) INHIBITORS MERCK CANADA INC. (CA) 2015-05-28 US disclosed
US-20150057448-A1 INTERMEDIATES FOR THE PREPARATION OF PYRIDIN-2-YL-AMINO-1,2,4-THIADIAZOLE DERIVATIVES ARRAY BIOPHARMA, INC. 2015-02-26 US disclosed
US-20150057448-A1 INTERMEDIATES FOR THE PREPARATION OF PYRIDIN-2-YL-AMINO-1,2,4-THIADIAZOLE DERIVATIVES ARRAY BIOPHARMA, INC. 2015-02-26 US disclosed
US-8853409-B2 Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus ARRAY BIOPHARMA INC. (US) 2014-10-07 US disclosed
US-20140273448-A1 COMPOSITION FOR FORMING TITANIUM-CONTAINING RESIST UNDERLAYER FILM AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-09-18 US disclosed
US-20140273448-A1 COMPOSITION FOR FORMING TITANIUM-CONTAINING RESIST UNDERLAYER FILM AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-09-18 US disclosed
US-20140273447-A1 COMPOSITION FOR FORMING TITANIUM-CONTAINING RESIST UNDERLAYER FILM AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-09-18 US disclosed
US-20140273447-A1 COMPOSITION FOR FORMING TITANIUM-CONTAINING RESIST UNDERLAYER FILM AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-09-18 US disclosed
EP-1888509-B1 BENZOYL-SUBSTITUTED SERINE AMIDES BASF SE (DE) 2013-05-15 EP disclosed
CN-103087222-A Olefin polymerization catalyst, process for producing olefin polymer, polypropylene resin composition and article comprising the same SUMITOMO CHEMICAL CO 2013-05-08 CN disclosed
US-20120277242-A1 Pyridin-2YL-Amino-1, 2, 4-Thiadiazole Derivatives as Glucokinase Activators for the Treatment of Diabetes Mellitus ARRAY BIOPHARMA, INC. (US) 2012-11-01 US disclosed
US-20120277242-A1 Pyridin-2YL-Amino-1, 2, 4-Thiadiazole Derivatives as Glucokinase Activators for the Treatment of Diabetes Mellitus ARRAY BIOPHARMA, INC. (US) 2012-11-01 US disclosed
US-8212045-B2 Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus ARRAY BIOPHARMA, INC. (US) 2012-07-03 US disclosed
US-8133851-B2 Heteroaroyl-substituted serine amides BASF SE (DE) 2012-03-13 US disclosed
US-20110318470-A1 Method For Improving Plant Health BASF SE (DE) 2011-12-29 US disclosed
US-20110209253-A1 Method for Improving Plant Health BASF SE (DE) 2011-08-25 US disclosed
US-7943649-B2 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors MERCK FROSST CANADA LTD. (CA) 2011-05-17 US disclosed
US-20110046059-A1 PHARMACEUTICALLY ACCEPTABLE FORMULATIONS/COMPOSITIONS FOR PEPTIDYL DRUGS ZELOS THERAPEUTICS, INC. (US) 2011-02-24 US disclosed
US-7879761-B2 Herbicides; 1-{Methylcarbamoyl-[(1-methyl-3-trifluoromethyl-1H-pyrazol-4-carbonyl)amino]methyl}-allyl acetate; acylation of keto compounds and reduction of the ketone, or the serine derivative is reacted with a heteroaryl acid and then with a secondary or tertiary amine BASF AKTIENGESELLSCHAFT (DE) 2011-02-01 US disclosed
EP-2121583-B1 HETEROARYL-SUBSTITUTED SERINE AMIDES BASF SE (DE) 2010-09-22 EP disclosed
US-7786046-B2 Benzoyl-substituted serineamides BASF AKTIENGESELLSCHAFT (DE) 2010-08-31 US disclosed
US-20100204240-A1 Pyridin-2-YL-Amino-1, 2, 4-Thiadiazole Derivatives as Glucokinase Activators for the Treatment of Diabetes Mellitus ARRAY BIOPHARMA INC. (US) 2010-08-12 US disclosed
US-20100099568-A1 Heteroaroyl-Substituted Serine Amides BASF SE (DE) 2010-04-22 US disclosed
EP-2121583-A1 HETEROARYL-SUBSTITUTED SERINE AMIDES BASF SE (DE) 2009-11-25 EP disclosed
US-20090215628-A1 Benzoyl-Substituted Alanines BASF SE (DE) 2009-08-27 US disclosed
US-20090209571-A1 Phenanthrene derivatives as MPGES-1 inhibitors CELLUMEN INC. 2009-08-20 US disclosed
US-20090192158-A1 Methods for Treating or Preventing Neoplasias MERCK FROSST CANADA LTD. (CA) 2009-07-30 US disclosed
US-20090186766-A1 Heteroaroyl-Substituted Alanines with a Herbicidal Action BASF SE (DE) 2009-07-23 US disclosed
US-20090075998-A1 2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors MERCK CANADA INC. (CA) 2009-03-19 US disclosed
US-20090054240-A1 Heteroaroyl-substituted Alanines BASF SE (DE) 2009-02-26 US disclosed
EP-2027095-A1 HETEROAROYL-SUBSTITUTED ALANINES WITH A HERBICIDAL ACTION BASF SE (DE) 2009-02-25 EP disclosed
EP-2024327-A1 BENZOYL-SUBSTITUTED ALANINES BASF SE (DE) 2009-02-18 EP disclosed
US-20090036311-A1 Benzoyl-Substituted Alanines BASF SE (DE) 2009-02-05 US disclosed
US-7468449-B2 Phenyl-furan compounds as vitamin D receptor modulators ELI LILLY AND COMPANY (US) 2008-12-23 US disclosed
EP-1253134-B1 Vinyl-polymerizable monomer having tertiary hydroxyl group and polymer MITSUBISHI GAS CHEMICAL CO (JP) 2008-11-26 EP disclosed
EP-1987015-A2 BENZOYL-SUBSTITUTED ALANINES BASF SE (DE) 2008-11-05 EP disclosed
EP-1987008-A2 HETEROAROYL-SUBSTITUTED ALANINES BASF SE (DE) 2008-11-05 EP disclosed
US-20080200338-A1 Heteroaroyl-Substituted Serineamides BASF AKTIENGESELLSCHAFT (DE) 2008-08-21 US disclosed
US-20080200542-A1 Benzoyl-Substituted Serineamides BASF AKTIENGESELLSCHAFT (DE) 2008-08-21 US disclosed
WO-2008084073-A1 HETEROARYL-SUBSTITUTED SERINE AMIDES BASF SE (DE) 2008-07-17 WO disclosed
WO-2008084070-A1 BENZOYL-SUBSTITUTED SERINE AMIDES BASF SE (DE) 2008-07-17 WO disclosed
EP-1692123-B1 PHENYL-FURAN COMPOUNDS AS VITAMIN D RECEPTOR MODULATORS LILLY CO ELI (US) 2008-05-28 EP disclosed
CN-100378061-C Vinyl polymerized monomer and polymer contg. tert-hydroxyl MITSUBISHI GAS CHEMICAL CO (JP) 2008-04-02 CN disclosed
EP-1888532-A1 HETEROAROYL-SUBSTITUTED SERINE AMIDES BASF AKTIENGESELLSCHAFT (DE) 2008-02-20 EP disclosed
EP-1888509-A1 BENZOYL-SUBSTITUTED SERINE AMIDES BASF AKTIENGESELLSCHAFT (DE) 2008-02-20 EP disclosed
WO-2007134984-A1 HETEROAROYL-SUBSTITUTED ALANINES WITH A HERBICIDAL ACTION BASF SE (DE) 2007-11-29 WO disclosed
WO-2007134971-A1 BENZOYL-SUBSTITUTED ALANINES BASF SE (DE) 2007-11-29 WO disclosed
WO-2007093529-A2 HETEROAROYL-SUBSTITUTED ALANINES BASF SE (DE) 2007-08-23 WO disclosed
WO-2007093539-A2 BENZOYL-SUBSTITUTED ALANINES BASF SE (DE) 2007-08-23 WO disclosed
US-7250157-B2 Dermatological compositions and methods APPLIED GENETICS INCORPORATED DERMATICS (US) 2007-07-31 US disclosed
US-20070105951-A1 Phenyl-furan compounds as vitamin d receptor modulators ELI LILLY AND COMPANY 2007-05-10 US disclosed
CN-1310963-C Catalyst component for olefin polymerization reaction and catalyst CHINA PETROCHEMICAL CORP (CN) 2007-04-18 CN disclosed
WO-2006125688-A1 BENZOYL-SUBSTITUTED SERINE AMIDES BASF AKTIENGESELLSCHAFT (DE) 2006-11-30 WO disclosed
WO-2006125687-A1 HETEROAROYL-SUBSTITUTED SERINE AMIDES BASF AKTIENGESELLSCHAFT (DE) 2006-11-30 WO disclosed
US-20060120976-A1 Dermatological compositions and methods APPLIED GENETICS INCORPORATED DERMATICS (US) 2006-06-08 US disclosed
US-6943144-B1 Concentrated stable, translucent or clear fabric softening compositions including chelants THE PROCTER & GAMBLE COMPANY (US) 2005-09-13 US disclosed
CN-1552741-A Catalyst component for olefin polymerization reaction and catalyst 中国石油化工股份有限公司 2004-12-08 CN disclosed
US-20040167309-A1 Vinyl-polymerizable monomer having tertiary hydroxyl group and polymer SAEGUSA NOBUYA (JP) 2004-08-26 US disclosed
US-20040067209-A1 Dermatological compositions and methods APPLIED GENETICS INCORPORATED DERMATICS 2004-04-08 US disclosed
US-6623724-B2 Regulating the melanin content of mammalian melanocytes by administering alcohols, diols, triols and their analogues APPLIED GENETICS INCORPORATED DERMATICS 2003-09-23 US disclosed
CN-1110541-C Concentrated water-dispersible stable fiber softener compositions PROCTER & GAMBLE (US) 2003-06-04 CN disclosed
US-20030040593-A1 Vinyl-polymerizable monomer having tertiary hydroxyl group and polymer MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2003-02-27 US disclosed
CN-1098350-C Fabric softening compound/composition PROCTER & GAMBLE (US) 2003-01-08 CN disclosed
CN-1382683-A Vinyl polymerized monomer and polymer contg. tert-hydroxyl MITSUBISHI GAS CHEMICAL CO (JP) 2002-12-04 CN disclosed
EP-1253134-A1 Vinyl-polymerizable monomer having tertiary hydroxyl group and polymer MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2002-10-30 EP disclosed
US-20020141952-A1 Regulating the melanin content of mammalian melanocytes by administering alcohols, diols, triols and their analogues APPLIED GENETICS INCORPORATED DERMATICS 2002-10-03 US disclosed
US-6323172-B1 AQUEOUS COMPOSITION COMPRISING FABRIC SOFTENER, SELECTED PRINCIPAL SOLVENT, LOW MOLECULAR WEIGHT WATER SOLUBLE SOLVENT TO IMPROVE CLARITY, WATER SOLUBLE CALCIUM AND/OR MAGNESIUM SALT THE PROCTER & GAMBLE COMPANY 2001-11-27 US disclosed
US-6294585-B1 ADMINISTERING NORBORNANE DIOL/TRIOL OR NORBORNENE DIOL/TRIOL DERIVATIVES FOR INCREASING DIFFERENTIATION OF MAMMALIAN NEURONAL CELLS APPLIED GENETICS INCORPORATED DERMATICS 2001-09-25 US disclosed
CN-1272133-A Concentrated, stable, preferably clear, fabric softening compositions containing amine fabric softeners PROCTER & GAMBLE (US) 2000-11-01 CN disclosed
CN-1263552-A softener actives derived from acylated triethanolamine PROCTER & GAMBLE (US) 2000-08-16 CN disclosed
EP-0982283-A2 Method for the separation of polyfunctional alcohols from water-soluble salts in aqueous systems Degussa-Hüls Aktiengesellschaft (DE) 2000-03-01 EP disclosed
CN-1244212-A Improved expression vectors PROCTER & GAMBLE (US) 2000-02-09 CN disclosed
US-5990177-A CYCLIC AND ACYCLIC MONO-, DI- AND TRIALCOHOLS AS STIMULANTS TO TREAT DISEASES MEDIATED BY DEFICIENCIES IN THE NITRIC OXIDE/CYCLIC GUANOSINE MONOPHOSPHATE/PROTEIN KINASE G SIGNAL TRANSDUCTION PATHWAY; CARDIOVASCULAR; SKIN; NERVOUS SYSTEM CODON PHARMACEUTICALS, INC. (US) 1999-11-23 US disclosed
CN-1219953-A Fabric softening compound/composition PROCTER & GAMBLE (US) 1999-06-16 CN disclosed
CN-1196081-A Concentrated, water dispersible, stable, fabric softening compositions PROCTER & GAMBLE (US) 1998-10-14 CN disclosed
CN-1195369-A Concentrated and stable fabric softening compositions PROCTER & GAMBLE (US) 1998-10-07 CN disclosed
US-5424323-A An antiseptic aqueous concentrate solution comsisting of two quaternary ammonium compounds, one dialdehyde and at least one aliphatic hydroxyl compound; microbiocides for nonabsorbent surfaces such as metal, ceramics, wood, medical equipment CETYLITE INDUSTRIES, INC. (US) 1995-06-13 US disclosed
US-5407949-A Biocide for killing bacteria, spores, fungi and viruses having two heterocyclic quaternary compounds, a dialdehyde and alcohol CETYLITE INDUSTRIES, INC. (US) 1995-04-18 US disclosed
US-5344838-A Quaternary ammonium compounds, dialdehyde, alcohol CETYLITE INDUSTRIES, INC. (US) 1994-09-06 US disclosed
US-5338748-A Storage stable aqueous mixture of heterocyclic and aliphatic quaternary ammonium compounds, aliphatic dialdehydes and aliphatic hydroxyl compounds CETYLITE INDUSTRIES, INC. (US) 1994-08-16 US disclosed
US-5266673-A Compatibilizer for polymer blends and alloys MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1993-11-30 US disclosed
EP-0530442-A1 Process for producing a hydroxy-substituted poly (phenylene ether) resin MITSUBISHI CHEMICAL CORPORATION (JP) 1993-03-10 EP disclosed
US-5124359-A At least one quaternary ammonium compound, aliphatic dialdehyde, and aliphatic hydroxyl compound; nonabsorbent surfaces; medical equipment CETYLITE INDUSTRIES, INC. (US) 1992-06-23 US disclosed
US-4708866-A METHACRYLATE MONOMERS AND POLYMERS; CALCIUM COMPOUND, LUBRICANT INTERNATIONAL CHEMICAL CORPORATION DBA INNOVATIVE CHEMICAL CORPORATION 1987-11-24 US disclosed
EP-0010236-B2 PROCESS FOR THE SYNTHESIS OF 2,3-DIMETHYL-2,3-BUTANE DIOL Ruhrchemie Aktiengesellschaft (DE) 1987-04-15 EP disclosed
US-4404410-A Process for preparing 2,3-dimethyl-2,3-butanediol RUHRCHEMIE AKTIENGESELLSCHAFT (DE) 1983-09-13 US disclosed
EP-0010236-B1 PROCESS FOR THE SYNTHESIS OF 2,3-DIMETHYL-2,3-BUTANE DIOL Ruhrchemie Aktiengesellschaft (DE) 1983-02-09 EP disclosed
EP-0010236-A1 Process for the synthesis of 2,3-dimethyl-2,3-butane diol Ruhrchemie Aktiengesellschaft (DE) 1980-04-30 EP disclosed
EP-0010236-A1 Process for the synthesis of 2,3-dimethyl-2,3-butane diol Ruhrchemie Aktiengesellschaft (DE) 1980-04-30 EP disclosed